Ruchin Kansal – författare

Most people marvel at the level of innovation demonstrated by the biopharmaceutical industry in bringing new products to the market – especially in the past 20 years. However, there is a crisis looming in the industry that should be a concern to all of us who take for granted the constant pace at which new treatments, and increasingly cures, have emerged from the laboratories of current sector incumbents. In the book, we examine the evolution of the biopharmaceutical industry to understand how it became what we term a "unicorn industry" with a unique, US-centered business model that has led to multiple blockbuster products (aka, unicorns) year after year. We explore how past success has created perceived barriers to innovation diversification beyond the chemical or biological-based biopharmaceutical product, and highlight the warning signs of the industry’s decline. We define a potential pathway for transforming the industry’s business model by broadening the definition, sources, and enablers of innovation beyond the traditional biopharmaceutical product. We introduce and advocate for the 80-80 Rule - "Being 80% confident that you will only be 80% right the first time should feel normal." The 80-80 Rule is a theme that emphasizes speed and willingness to embrace uncertainty and overcome internal barriers to change. It sets the standard for redefining innovation as a platform to reignite growth of the biopharmaceutical industry.

Work Signals is the practical, empowering guide you wish you had at the start of your career.Most professionals spend up to two-thirds of their lives working in organizations, yet move through their careers without fully understanding the unwritten rules, the power dynamics, or what it truly takes to get recognized, get ahead, and get promoted. Your career takes off when you understand the game of work and how value gets recognized. Work Signals is the missing playbook for professionals building careers and leaders building organizations who know that talent alone is not enough. Unlike other career books, it takes a systems-based, human-centered approach and shows you how to create value that matters, make your contributions visible without becoming performative or manipulative, build trust that compounds, read culture and power dynamics with clarity, create options, and stay adaptable in a world that keeps changing. Each chapter includes reflective questions, practical tools, and real-world case studies you can apply immediately.Whether you are early in your career, a student, a middle manager aiming to lead with more clarity and confidence, or a senior leader looking to build a resilient organization, this is the playbook you will return to again and again for winning in the complex world of organizations.

Work Signals is the practical, empowering guide you wish you had at the start of your career.Most professionals spend up to two-thirds of their lives working in organizations, yet move through their careers without fully understanding the unwritten rules, the power dynamics, or what it truly takes to get recognized, get ahead, and get promoted. Your career takes off when you understand the game of work and how value gets recognized. Work Signals is the missing playbook for professionals building careers and leaders building organizations who know that talent alone is not enough. Unlike other career books, it takes a systems-based, human-centered approach and shows you how to create value that matters, make your contributions visible without becoming performative or manipulative, build trust that compounds, read culture and power dynamics with clarity, create options, and stay adaptable in a world that keeps changing. Each chapter includes reflective questions, practical tools, and real-world case studies you can apply immediately.Whether you are early in your career, a student, a middle manager aiming to lead with more clarity and confidence, or a senior leader looking to build a resilient organization, this is the playbook you will return to again and again for winning in the complex world of organizations.

Most people marvel at the level of innovation demonstrated by the biopharmaceutical industry in bringing new products to the market – especially in the past 20 years. However, there is a crisis looming in the industry that should be a concern to all of us who take for granted the constant pace at which new treatments, and increasingly cures, have emerged from the laboratories of current sector incumbents. In the book, we examine the evolution of the biopharmaceutical industry to understand how it became what we term a "unicorn industry" with a unique, US-centered business model that has led to multiple blockbuster products (aka, unicorns) year after year. We explore how past success has created perceived barriers to innovation diversification beyond the chemical or biological-based biopharmaceutical product, and highlight the warning signs of the industry’s decline. We define a potential pathway for transforming the industry’s business model by broadening the definition, sources, and enablers of innovation beyond the traditional biopharmaceutical product. We introduce and advocate for the 80-80 Rule - "Being 80% confident that you will only be 80% right the first time should feel normal." The 80-80 Rule is a theme that emphasizes speed and willingness to embrace uncertainty and overcome internal barriers to change. It sets the standard for redefining innovation as a platform to reignite growth of the biopharmaceutical industry.